Abbott expands by acquisition

An acquisition gives Abbott a leadership position in another large and growing medical device segment.
Abbott and Advanced Medical Optics, AMO, have announced a definitive agreement for Abbott to acquire AMO for USD 22 per share in cash. The total transaction value is approximately USD 2,8 billion, inclusive of estimated net debt at the time of closing.

Based in Santa Ana, in California, AMO is a global leader in ophthalmic care, comprised of three segments: cataract surgery, laser vision correction, Lasik, and eye care products. Globally, AMO holds the number one position in Lasik surgical devices, the number two position in the cataract surgical device market and the number three position in contact lens care products.

Population growth and demographic shifts are increasing demand for advanced vision care technologies across all geographies and age groups. For example, about 60 percent of people older than 60 have cataracts, which are the leading cause of vision loss among this age group. It is estimated that 700 million people globally are 60 years or older, and that number is expected to grow to one billion over the next decade.
Kommentera en artikel
Utvalda artiklar


Sänd till en kollega